VIA
LUMO

Vantage Investment Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Vantage Investment Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-56
Closed -$14K – 732
2014
Q1 		$14K Buy
+56
New +$17.1K 0.01% 395

Other funds holding LUMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Vantage Investment Advisors's LUMO Position: Q2 2014 in Review

Vantage Investment Advisors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2014, closing a stake of 56 shares — an estimated $14K sold.

Vantage Investment Advisors first reported a position in LUMO in Q1 2014 and held it in 1 quarter. The position peaked at $14K in Q1 2014. 88 funds tracked by Wall St. Rank hold LUMO as of Q2 2014.

  • Vantage Investment Advisors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Vantage Investment Advisors sold 56 Lumos Pharma, Inc. Common Stock shares in Q2 2014, an estimated $14K.
  • Vantage Investment Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2014 and held it in 1 quarter.
  • Vantage Investment Advisors's Lumos Pharma, Inc. Common Stock position peaked at $14K in Q1 2014.
  • 88 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2014.

Based on Vantage Investment Advisors's 13F filing for Q2 2014, filed 25 Jul 2014.